Stocks · Health care · Biological Products, (No Diagnostic Substances)

CRISPR Therapeutics AG

CRSP Clue Score37
Switzerland Fiscal year ends December CIK 0001674416 Results filed 2 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Samarth Kulkarni
19 Oct 2026
Chief Executive Officer
Sell
47,837
$49.78
$2.38M
Simeon George
14 Oct 2026
Director
Sold after exercise
14,514
$49.63
$720.37K
Samarth Kulkarni
14 Oct 2026
Chief Executive Officer
Sell
4,098
$49.26
$201.87K
James R. Kasinger
14 Oct 2026
General Counsel and Secretary
Sell
1,040
$49.26
$51.23K
James R. Kasinger
6 Oct 2026
General Counsel and Secretary
Sold after exercise
1,990
$60.04
$119.48K
James R. Kasinger
22 Sep 2026
General Counsel and Secretary
Sold after exercise
10,400
$60.24
$626.46K
Ali Behbahani
17 Sep 2026
Director
Sold after exercise
13,679
$57.09
$780.94K
Naimish Patel
29 May 2026
Chief Medical Officer
Sell
3,786
$55.62
$210.58K
Raju Prasad
23 Mar 2026
Chief Financial Officer
Sell
3,708
$46.78
$173.46K
Samarth Kulkarni
23 Mar 2026
Chief Executive Officer
Sell
10,020
$46.78
$468.74K
James R. Kasinger
23 Mar 2026
General Counsel and Secretary
Sell
3,182
$46.78
$148.85K
Samarth Kulkarni
16 Mar 2026
Chief Executive Officer
Sell
10,349
$48.26
$499.44K
James R. Kasinger
16 Mar 2026
General Counsel and Secretary
Sell
3,450
$48.26
$166.50K
Raju Prasad
16 Mar 2026
Chief Financial Officer
Sell
4,021
$48.26
$194.05K
Raju Prasad
16 Mar 2026
Chief Financial Officer
Sell
5,848
$48.26
$282.22K
Naimish Patel
16 Mar 2026
Chief Medical Officer
Sell
3,150
$48.26
$152.02K
Samarth Kulkarni
11 Mar 2026
Chief Executive Officer
Sell
9,798
$52.80
$517.33K
James R. Kasinger
11 Mar 2026
General Counsel and Secretary
Sell
2,800
$52.80
$147.84K
James R. Kasinger
19 Feb 2026
General Counsel and Secretary
Sell
2,112
$52.58
$111.05K
Samarth Kulkarni
19 Feb 2026
Chief Executive Officer
Sell
6,967
$52.58
$366.32K
Samarth Kulkarni
22 Jan 2026
Chief Executive Officer
Sold on a plan
60,000
$60.23
$3.61M
Raju Prasad
22 Jan 2026
Chief Financial Officer
Sold after exercise
34,972
$60.19
$2.10M
Samarth Kulkarni
20 Jan 2026
Chief Executive Officer
Sold on a plan
8,567
$52.10
$446.34K
Samarth Kulkarni
20 Jan 2026
Chief Executive Officer
Sold on a plan
21,433
$51.61
$1.11M
Raju Prasad
6 Jan 2026
Chief Financial Officer
Sold after exercise
5,763
$60.21
$347.01K
Raju Prasad
6 Jan 2026
Chief Financial Officer
Sold after exercise
5,004
$60.00
$300.24K
Raju Prasad
6 Jan 2026
Chief Financial Officer
Sold after exercise
18,933
$60.18
$1.14M
Raju Prasad
22 Dec 2025
Chief Financial Officer
Sold on a plan
1,000
$56.89
$56.89K
Raju Prasad
22 Dec 2025
Chief Financial Officer
Sold on a plan
5,472
$56.33
$308.26K
Raju Prasad
22 Dec 2025
Chief Financial Officer
Sold on a plan
3,528
$55.10
$194.40K

What was left out

Form 4 filings counted 46
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 6
Sales straight out of an exercise 8
Sales at will 16
Transactions with no price 0
Shares from compensation/vesting 415,520
History held since 20 Oct 2016